FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Jorgensen

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Jose Cadena; Andres Henao-Martinez; James Jorgensen; Shalini Nair; Pranavi Sreeramoju; Jan Patterson
Clindamycin-resistant methicillin-resistant Staphylococcus aureus: epidemiologic and molecular characteristics and associated clinical factors.
Chih-Ko Yeh; Yong-Hee Patricia Chun; Roberto Fajardo; Stephen E Harris; Diane Horn; James Jorgensen; Mary MacDougall; Sumathy Mohan; Sherry Abboud-Werner
Hyperglycemia and xerostomia are key determinants of tooth decay in type 1 diabetic mice.
James R Johnson; Brian D Johnston; James Jorgensen; Michael A Kuskowski; James S Lewis; David Paterson; John Quinn; Ari Robicsek; Carl Urban; Scott J Weissman; Javier Adachi; Connie Clabots; Timothy Cleary; Paul H Edelstein; Glen Hansen; Nancy D Hanson
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Jorgensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jose Cadena; Andres Henao-Martinez; James Jorgensen; Shalini Nair; Pranavi Sreeramoju; Jan Patterson
Clindamycin-resistant methicillin-resistant Staphylococcus aureus: epidemiologic and molecular characteristics and associated clinical factors.
Diagnostic microbiology and infectious disease 2012;74(1):16-21.
2012: Chih-Ko Yeh; Yong-Hee Patricia Chun; Roberto Fajardo; Stephen E Harris; Diane Horn; James Jorgensen; Mary MacDougall; Sumathy Mohan; Sherry Abboud-Werner
Hyperglycemia and xerostomia are key determinants of tooth decay in type 1 diabetic mice.
Laboratory investigation; a journal of technical methods and pathology 2012;92(6):868-82.
2012: James R Johnson; Brian D Johnston; James Jorgensen; Michael A Kuskowski; James S Lewis; David Paterson; John Quinn; Ari Robicsek; Carl Urban; Scott J Weissman; Javier Adachi; Connie Clabots; Timothy Cleary; Paul H Edelstein; Glen Hansen; Nancy D Hanson
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
Antimicrobial agents and chemotherapy 2012;56(5):2364-70.
2012: Yoon Soo Park; Kathleen A Shutt; Daniel M Yarabinec; Jennifer M Adams-Haduch; Ameet Hingwe; Laura E Johnson; James Jorgensen; James S Lewis; Yohei Doi
Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States.
Antimicrobial agents and chemotherapy 2012;56(4):1870-6.
2012: Jennifer D Campbell; Letitia C Fulcher; James S Lewis; M Leticia McElmeel; James Jorgensen
Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.
Journal of clinical microbiology 2012;50(3):1023-6.
2012: Lee M Hampton; Elizabeth R Zell; Bernard W. Beall; Susan Petit; Ruth Lynfield; Kenneth Gershman; Ann Thomas; Monica M Farley; Arthur Reingold; Anita Glennen; Joan Baumbach; Nancy M Bennett; William Schaffner; Lee H Harrison; James Jorgensen; Matthew Moore
Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
The Journal of infectious diseases 2012;205(3):401-11.
2011: Katharine L Gray; M Leticia McElmeel; Elly Marie-Jeaanne Xenakis; Letitia C Fulcher; James Jorgensen
The outpatient institutional antibiogram does not accurately reflect the susceptibility of prepartum group B streptococcal isolates to erythromycin and clindamycin.
Diagnostic microbiology and infectious disease 2011;71(4):457-9.
2011: Jose Cadena; Andres F Henao-Martinez; James Jorgensen; Shalini Nair; Jan Patterson; Pranavi V Sreeramoju
Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2011;55(12):5430-2.
2011: G R Thompson; T C Haman; Brian L Wickes; M L Herrera; J S Lewis; James Jorgensen
Disseminated Burkholderia gladioli infection in a lung transplant recipient with underlying hypocomplementemic urticarial vasculitis.
Transplant infectious disease : an official journal of the Transplantation Society 2011;13(6):641-5.
2011: Nicolas A Forcade; Liem C Du; James Jorgensen; Michael W Mann; Eric Mortensen; Abilio Muñoz; Natalie R Nyren; Michael L Parchman; Joel Peña; Brad H Pollock; Lucina B Treviño; Sylvia B Treviño; Brian L Wickes; Christopher Frei
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study.
Journal of the American Board of Family Medicine : JABFM 2011;24(5):543-50.
2011: James Jorgensen; M Leticia McElmeel; Lesley McGee; Letitia C Fulcher; Anita Glennen
Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae.
Journal of clinical microbiology 2011;49(9):3332-3.
2011: James Jorgensen; M Leticia McElmeel; Lesley McGee; Sandra S Richter; Jean Spargo; Mary Jane Ferraro; Letitia C Fulcher; K P Heilmann; Anita Glennen
Collaborative evaluation of an erythromycin-clindamycin combination well for detection of inducible clindamycin resistance in beta-hemolytic streptococci by use of the CLSI broth microdilution method.
Journal of clinical microbiology 2011;49(8):2884-6.
2011: Federico Palacio; Lee Sadkowski; Kelly Echevarria; James S Lewis; James Jorgensen
Breakthrough bacteremia and septic shock due to Streptococcus anginosus resistant to daptomycin in a patient receiving daptomycin therapy.
Antimicrobial agents and chemotherapy 2011;55(7):3639-40.
2011: Carlos J Sanchez; Pooja Shivshankar; Nikhil Kumar; Anel Lizcano; James Jorgensen; Hervé Tettelin; Julie C Dunning Hotopp; Carlos Orihuela
Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production.
PloS one 2011;6(12):e28738.
2010: Nelson Torres; Sunho Oh; Mark Appleford; David Dean; James Jorgensen; Joo L Ong; C Mauli Agrawal; Gopinath Mani
Stability of antibacterial self-assembled monolayers on hydroxyapatite.
Acta biomaterialia 2010;6(8):3242-55.
2010: Jana M Swenson; Betty Wong; Andrew E Simor; Richard B Thomson; Mary Jane Ferraro; Dwight J Hardy; Janet Hindler; James Jorgensen; L Barth Reller; Maria M Traczewski; Linda McDougal; Jean B Patel
Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus.
Journal of clinical microbiology 2010;48(7):2469-75.
2010: Jason E Bowling; Aaron E Owens; M Leticia McElmeel; Letitia C Fulcher; Monica L Herrera; Brian L Wickes; James Jorgensen
Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.
Journal of clinical microbiology 2010;48(6):2275-7.
2010: Jason W Bennett; Katrin Mende; Monica L Herrera; Xin Yu; James S Lewis; Brian L Wickes; James Jorgensen; Clinton Murray
Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
Diagnostic microbiology and infectious disease 2010;66(4):445-8.
2010: Robert E Gertz; Zhongya Li; Fabiana C Pimenta; Delois Jackson; Billie A Juni; Ruth Lynfield; James Jorgensen; Maria da Gloria Carvalho; Bernard W. Beall
Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.
The Journal of infectious diseases 2010;201(5):770-5.
2010: Alison H Skalet; Vicky Cevallos; Berhan Ayele; Teshome Gebre; Zhaoxia Zhou; James Jorgensen; Mulat Zerihun; Dereje Habte; Yibeltal Assefa; Paul M Emerson; Bruce D Gaynor; Travis C Porco; Thomas Lietman; Jeremy D Keenan
Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
PLoS medicine 2010;7(12):e1000377.
2010: Trent G Towne; James S Lewis; Monica Herrera; Brian L Wickes; James Jorgensen
Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.
Journal of clinical microbiology 2010;48(1):298-9.
2010: James Jorgensen; M Leticia McElmeel; L C Fulcher; B L Zimmer
Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels.
Journal of clinical microbiology 2010;48(1):120-3.
2009: James Jorgensen; Mary Jane Ferraro
Antimicrobial susceptibility testing: a review of general principles and contemporary practices.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(11):1749-55.
2009: Anna Woodbury; James Jorgensen; Aaron Owens; Andres Henao-Martinez
Moraxella lacunata septic arthritis in a patient with lupus nephritis.
Journal of clinical microbiology 2009;47(11):3787-8.
2009: Michael W Ellis; Matthew E Griffith; James Jorgensen; Duane R Hospenthal; Katrin Mende; Jan Patterson
Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers.
Journal of clinical microbiology 2009;47(4):940-5.
2009: Vidhya Prakash; James S Lewis; Monica L Herrera; Brian L Wickes; James Jorgensen
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Antimicrobial agents and chemotherapy 2009;53(3):1278-80.
2009: Heather E Hsu; Kathleen A Shutt; Matthew R Moore; Bernard W. Beall; Nancy M Bennett; Allen S Craig; Monica M Farley; James Jorgensen; Catherine A Lexau; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Cynthia G Whitney; Lee H Harrison
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.
The New England journal of medicine 2009;360(3):244-56.
2009: Jason W Bennett; Monica L Herrera; James S Lewis; Brian L Wickes; James Jorgensen
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
Antimicrobial agents and chemotherapy 2009;53(1):292-4.
2008: V Prakash; J S Lewis; James Jorgensen
Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used.
Antimicrobial agents and chemotherapy 2008;52(12):4528.
2008: Matthew R Moore; Robert E Gertz; Robyn L Woodbury; Genevieve A Barkocy-Gallagher; William Schaffner; Catherine A Lexau; Kenneth Gershman; Arthur Reingold; Monica M Farley; Lee H Harrison; James L Hadler; Nancy M Bennett; Ann R Thomas; Lesley McGee; Tamara Pilishvili; Angela B Brueggemann; Cynthia G Whitney; James Jorgensen; Bernard W. Beall
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
The Journal of infectious diseases 2008;197(7):1016-27.
2008: Jason W Bennett; Clinton Murray; Robert L Holmes; Jan Patterson; James Jorgensen
Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Diagnostic microbiology and infectious disease 2008;60(4):437-40.
2008: Roseanne A Ressner; Matthew R Moore; James Jorgensen
Activity of the Diaminopyrimidine AR-709 against recently collected multidrug-resistant isolates of invasive Streptococcus pneumoniae from North America.
Antimicrobial agents and chemotherapy 2008;52(3):1147-9.
2008: Robert L Holmes; James Jorgensen
Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.
Antimicrobial agents and chemotherapy 2008;52(2):757-60.
2008: Joshua S Hawley; Clinton Murray; James Jorgensen
Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.
Antimicrobial agents and chemotherapy 2008;52(1):351-2.
2007: Heather C Yun; Michael W Ellis; James Jorgensen
Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees.
Diagnostic microbiology and infectious disease 2007;59(4):463-6.
2007: Joshua S Hawley; Clinton Murray; James Jorgensen
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Antimicrobial agents and chemotherapy 2007;51(12):4529-30.
2007: James S Lewis; Monica Herrera; Brian L Wickes; Jan Patterson; James Jorgensen
First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Antimicrobial agents and chemotherapy 2007;51(11):4015-21.
2007: Michael W Ellis; Matthew E Griffith; David P Dooley; Joseph C McLean; James Jorgensen; Jan Patterson; Kepler A Davis; Joshua S Hawley; Jason A Regules; Robert G Rivard; Paula J Gray; Julia M Ceremuga; Mary A Dejoseph; Duane R Hospenthal
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Antimicrobial agents and chemotherapy 2007;51(10):3591-8.
2007: James Jorgensen; Janet F Hindler
New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(2):280-6.
2007: David S Burgess; Christopher Frei; J S Lewis Ii; Kristin Fiebelkorn; James Jorgensen
The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2007;13(1):33-9.
2007: Joshua S Hawley; Clinton Murray; Matthew E Griffith; M Leticia McElmeel; Letitia C Fulcher; Duane R Hospenthal; James Jorgensen
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
Antimicrobial agents and chemotherapy 2007;51(1):376-8.
2006: Cynthia G Whitney; Tamara Pilishvili; Monica M Farley; William Schaffner; Allen S Craig; Ruth Lynfield; Ann-Christine Nyquist; Ken Gershman; Marietta Vazquez; Nancy M Bennett; Arthur Reingold; Ann Thomas; Mary P Glode; Elizabeth R Zell; James Jorgensen; Bernard W. Beall; Anne Schuchat
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.
Lancet 2006;368(9546):1495-502.
2006: James Jorgensen; Sharon A Crawford
Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
Journal of clinical microbiology 2006;44(6):2126-9.
2006: James Jorgensen; Sharon A Crawford; Letitia C Fulcher; Anita Glennen; Susan M Harrington; Jana Swenson; Ruth Lynfield; Patrick R Murray; Fred C Tenover
Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates.
Journal of clinical microbiology 2006;44(5):1744-54.
2006: Moe H Kyaw; Ruth Lynfield; William Schaffner; Allen S Craig; James L Hadler; Arthur Reingold; Ann R Thomas; Lee H Harrison; Nancy M Bennett; Monica M Farley; Richard R Facklam; James Jorgensen; John M Besser; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
The New England journal of medicine 2006;354(14):1455-63.
2006: Shelly R Gunn; Xavier T Reveles; Jeanette D Hamlington; Lee C Sadkowski; Teresa Johnson-Pais; James Jorgensen
Use of DNA sequencing analysis to confirm fungemia due to Trichosporon dermatis in a pediatric patient.
Journal of clinical microbiology 2006;44(3):1175-7.
2005: Wonkeun Song; Ellen Smith Moland; Nancy D Hanson; James S Lewis; James Jorgensen; Kenneth S Thomson
Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
Journal of clinical microbiology 2005;43(9):4891-4.
2005: Nicole Wolter; Anthony M Smith; David J Farrell; William Schaffner; Matthew Moore; Cynthia G Whitney; James Jorgensen; keith klugman
Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus.
Antimicrobial agents and chemotherapy 2005;49(8):3554-7.
2005: James Jorgensen; Sharon A Crawford; Kristin Fiebelkorn
Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.
Journal of clinical microbiology 2005;43(7):3162-71.
2005: Kepler A Davis; Sharon A Crawford; Kristin Fiebelkorn; James Jorgensen
Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.
Antimicrobial agents and chemotherapy 2005;49(7):3059-61.
2005: M Catherine McEllistrem; Jennifer M Adams; Kathleen A Shutt; Laurie T Sanza; Richard R Facklam; Cynthia G Whitney; James Jorgensen; Lee H Harrison
Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001.
Emerging infectious diseases 2005;11(6):969-72.
2005: Adrian M Zelazny; Mary Jane Ferraro; Anita Glennen; Janet F Hindler; Linda M Mann; Susan Munro; Patrick R Murray; L Barth Reller; Fred C Tenover; James Jorgensen
Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study.
Journal of clinical microbiology 2005;43(6):2613-5.
2005: James S Lewis; Aaron Owens; Jose Cadena; Kathryn Sabol; Jan Patterson; James Jorgensen
Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
Antimicrobial agents and chemotherapy 2005;49(4):1664-5.
2005: Sharon A Crawford; Kristin Fiebelkorn; Jan Patterson; James Jorgensen
International clone of Neisseria meningitidis serogroup A with tetracycline resistance due to tet(B).
Antimicrobial agents and chemotherapy 2005;49(3):1198-200.
2005: Kristin Fiebelkorn; Sharon A Crawford; James Jorgensen
Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents.
Antimicrobial agents and chemotherapy 2005;49(2):536-40.
2005: James S Lewis; James Jorgensen
Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(2):280-5.
2004: James Jorgensen; Sharon A Crawford; L M McElmeel; Cynthia G Whitney
Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.
Journal of clinical microbiology 2004;42(12):5928-30.
2004: Juan Gea-Banacloche; Steven M Opal; James Jorgensen; Joseph A Carcillo; Kent A Sepkowitz; Catherine Cordonnier
Sepsis associated with immunosuppressive medications: an evidence-based review.
Critical care medicine 2004;32(11 Suppl):S578-90.
2004: Jonathan Cohen; Christian Brun-Buisson; Antoni Torres; James Jorgensen
Diagnosis of infection in sepsis: an evidence-based review.
Critical care medicine 2004;32(11 Suppl):S466-94.
2004: Mathias Pletz; Lesley McGee; James Jorgensen; Bernard W. Beall; Richard R Facklam; Cynthia G Whitney; keith klugman
Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.
Antimicrobial agents and chemotherapy 2004;48(9):3491-7.
2004: Stephanie J Schrag; Lesley McGee; Cynthia G Whitney; Bernard W. Beall; Allen S Craig; Miriam E Choate; James Jorgensen; Richard R Facklam; keith klugman
Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.
Antimicrobial agents and chemotherapy 2004;48(8):3016-23.
2004: Nuala B Porteous; Spencer Redding; James Jorgensen
Isolation of non-tuberculosis mycobacteria in treated dental unit waterlines.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2004;98(1):40-4.
2004: James Jorgensen
Who defines resistance? The clinical and economic impact of antimicrobial susceptibility testing breakpoints.
Seminars in pediatric infectious diseases 2004;15(2):105-8.
2004: James Jorgensen; Sharon A Crawford; M Leticia McElmeel; Kristin Fiebelkorn
Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing.
Journal of clinical microbiology 2004;42(4):1800-2.
2004: James Jorgensen
Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.
Journal of clinical microbiology 2004;42(2):493-6.
2004: James Jorgensen; Sharon A Crawford; M Leticia McElmeel; Cynthia G Whitney
Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2004;48(2):605-7.
2003: James Jorgensen; Sharon A Crawford; Cynthia C Kelly; Jan Patterson
In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods.
Antimicrobial agents and chemotherapy 2003;47(12):3760-3.
2003: David S Burgess; Ronald G Hall; James S Lewis; James Jorgensen; Jan Patterson
Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.
Pharmacotherapy 2003;23(10):1232-7.
2003: Kristin Fiebelkorn; Sharon A Crawford; M Leticia McElmeel; James Jorgensen
Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.
Journal of clinical microbiology 2003;41(10):4740-4.
2003: Gregory Deye; James Lewis; Jan Patterson; James Jorgensen
A case of Leuconostoc ventriculitis with resistance to carbapenem antibiotics.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(6):869-70.
2003: Marcos Restrepo; J A Velez; M Leticia McElmeel; Cynthia G Whitney; James Jorgensen
Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2003;47(9):2974-7.
2003: Cynthia G Whitney; Monica M Farley; James L Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James Jorgensen; Anne Schuchat
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
The New England journal of medicine 2003;348(18):1737-46.
2003: Matthew J Hepburn; Gennethel J Pennick; Deanna A Sutton; G E Crawford; James Jorgensen
Candida krusei renal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving AmBisome.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2003;41(2):163-5.
2002: Sue E Baum; Sharon A Crawford; M Leticia McElmeel; Cynthia G Whitney; James Jorgensen
Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2002;46(9):3094-5.
2002: Bernard W. Beall; M Catherine McEllistrem; Robert E Gertz; David J Boxrud; John M Besser; Lee H Harrison; James Jorgensen; Cynthia G Whitney
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.
The Journal of infectious diseases 2002;186(1):118-22.
2002: Daniel M Musher; Mark E Dowell; Virginia D Shortridge; Robert K Flamm; James Jorgensen; Pierre Le Magueres; Kurt L Krause
Emergence of macrolide resistance during treatment of pneumococcal pneumonia.
The New England journal of medicine 2002;346(8):630-1.
2001: Marcos Restrepo; James Jorgensen; Eric Mortensen; Antonio Anzueto
Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy.
Current opinion in infectious diseases 2001;14(6):703-9.
2001: Terri B Hyde; Kathryn Gay; David S Stephens; Duc J Vugia; Margaret Pass; Scott B Johnson; Nancy L Barrett; William Schaffner; Paul R Cieslak; P S Maupin; Elizabeth R Zell; James Jorgensen; Richard R Facklam; Cynthia G Whitney
Macrolide resistance among invasive Streptococcus pneumoniae isolates.
JAMA : the journal of the American Medical Association 2001;286(15):1857-62.
2001: JF Moroney; Anthony E Fiore; Lee H Harrison; Jan Patterson; Monica M Farley; James Jorgensen; Maureen Phelan; Richard R Facklam; Martin S Cetron; Robert Breiman; Margarette S Kolczak; Anne Schuchat
Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(6):797-805.
2001: Clinton Murray; E A Walter; S Crawford; M Leticia McElmeel; James Jorgensen
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(10):E140-2.
2001: Carolina Echeverri; J Matherne; James Jorgensen; L J Fowler
Fite stain positivity in Rhodococcus equi: yet another acid-fast organism in respiratory cytology--a case report.
Diagnostic cytopathology 2001;24(4):244-6.
2001: Gregory M Anstead; James Jorgensen; F Craig; Martin Blaser; Thomas Patterson
Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(2):295-6.
2000: Cynthia G Whitney; Monica M Farley; James L Hadler; Lee H Harrison; Catherine A Lexau; Arthur Reingold; Lewis Lefkowitz; Paul R Cieslak; Martin S Cetron; Elizabeth R Zell; James Jorgensen; Anne Schuchat
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
The New England journal of medicine 2000;343(26):1917-24.
2000: James Jorgensen; L M Weigel; Jana M Swenson; C G Whitney; Mary Jane Ferraro; Fred C Tenover
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2000;44(11):2962-8.
2000: James Jorgensen; Arthur L Barry; Maria M Traczewski; D F Sahm; M Leticia McElmeel; Sharon A Crawford
Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.
Journal of clinical microbiology 2000;38(8):2814-8.
2000: Jan Patterson; Thomas C Hardin; C A Kelly; R C Garcia; James Jorgensen
Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2000;21(7):455-8.
2000: James D Heffelfinger; Scott F Dowell; James Jorgensen; keith klugman; L R Mabry; D M Musher; J F Plouffe; A Rakowsky; Anne Schuchat; Cynthia G Whitney
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Archives of internal medicine 2000;160(10):1399-408.
2000: James Jorgensen; Mary Jane Ferraro
Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(5):799-808.
2000: Jan Patterson; Jay Peters; John Calhoon; Stephanie M Levine; Antonio Anzueto; Hail M Al-Abdely; R Sanchez; Thomas Patterson; M Rech; James Jorgensen; Michael G Rinaldi; Edward Sako; Scott B Johnson; V Speeg; Glenn A Halff; JK Trinkle
Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2000;2(1):22-8.
2000: Daniel R Feikin; Anne Schuchat; Margarette S Kolczak; Nancy L Barrett; Lee H Harrison; Lewis Lefkowitz; Allison McGeer; Monica M Farley; Duc J Vugia; Catherine A Lexau; Karen Stefonek; Jan Patterson; James Jorgensen
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.
American journal of public health 2000;90(2):223-9.
2000: Anthony E Fiore; JF Moroney; Monica M Farley; Lee H Harrison; Jan Patterson; James Jorgensen; Martin S Cetron; Margarette S Kolczak; Robert Breiman; Anne Schuchat
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(1):71-7.
1999: Fred C Tenover; Ronald Jones; Jana M Swenson; Barbara L Zimmer; Sigrid McAllister; James Jorgensen
Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study.
Journal of clinical microbiology 1999;37(12):4051-8.
1999: S C Kim; James Jorgensen; John Graybill; J Smith
Otomastoiditis caused by Rhodococcus equi in a patient with AIDS.
Puerto Rico health sciences journal 1999;18(3):285-8.
1999: James Jorgensen; L M Weigel; Mary Jane Ferraro; Jana M Swenson; Fred C Tenover
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.
Antimicrobial agents and chemotherapy 1999;43(2):329-34.
1999: James Jorgensen; J R Salinas; R Paxson; K Magnon; Jan Patterson; Thomas Patterson
False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections.
Journal of clinical microbiology 1999;37(1):175-8.
1998: Linda McDougal; Fred C Tenover; linda lee; J Kamile Rasheed; Jan Patterson; James Jorgensen; D J LeBlanc
Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 1998;42(9):2312-8.
1998: James Jorgensen; Mary Jane Ferraro
Antimicrobial susceptibility testing: general principles and contemporary practices.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(4):973-80.
1998: Patricia A Meier; David P Dooley; James Jorgensen; C C Sanders; W M Huang; Jan Patterson
Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1998;177(4):951-4.
1998: James Jorgensen; M Leticia McElmeel; Sharon A Crawford
Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates.
Journal of clinical microbiology 1998;36(3):788-91.
1997: James Jorgensen
Laboratory issues in the detection and reporting of antibacterial resistance.
Infectious disease clinics of North America 1997;11(4):785-802.
1997: Susan L Fraser; James Jorgensen
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.
Antimicrobial agents and chemotherapy 1997;41(12):2738-41.
1997: James Jorgensen; J A Skweres; S K Mishra; M Leticia McElmeel; L A Maher; R Mulder; M V Lancaster; Duane L Pierson
Development of an antimicrobial susceptibility testing method suitable for performance during space flight.
Journal of clinical microbiology 1997;35(8):2093-7.
1997: G M Woods; James Jorgensen; M A Waclawiw; C Reid; W Wang; Charles H Pegelow; Zora R Rogers; Rathi V Iyer; C T Holbrook; T R Kinney; Elliott Vichinsky; Michael R DeBaun; N J Grossman; M D Thomas; J M Falletta
Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II.
Journal of pediatric hematology/oncology 1997;19(4):327-33.
1997: James Jorgensen; M Leticia McElmeel
Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
The Journal of antimicrobial chemotherapy 1997;39 Suppl A():69-73.
1997: Peter C Fuchs; Arthur L Barry; S D Brown; S D Allen; M Bauman; James Jorgensen; Fred C Tenover
Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619.
Diagnostic microbiology and infectious disease 1997;28(1):27-9.
1997: L L Dever; James Jorgensen; A G Barbour
In vitro susceptibility testing of Borrelia burgdorferi by a dialysis culture method.
Antimicrobial agents and chemotherapy 1997;41(5):1208-9.
1997: James Jorgensen; M Leticia McElmeel; C W Trippy
In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
Antimicrobial agents and chemotherapy 1997;41(2):465-7.
1997: James Jorgensen; Stanley Mirrett; L Clifford McDonald; Patrick R Murray; Melvin P Weinstein; J Fune; C W Trippy; M Masterson; L Barth Reller
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia.
Journal of clinical microbiology 1997;35(1):53-8.
1996: R J Kazragis; L L Dever; James Jorgensen; Alan G Barbour
In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
Antimicrobial agents and chemotherapy 1996;40(11):2632-6.
1996: James Jorgensen; M Leticia McElmeel; C W Trippy
Comparison of inoculation methods for testing enterococci by using vancomycin screening agar.
Journal of clinical microbiology 1996;34(11):2841-2.
1996: James Jorgensen; J M Swenson; Fred C Tenover; A Barry; M J Ferraro; P R Murray; L Barth Reller
Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
Journal of clinical microbiology 1996;34(11):2679-84.
1996: J A Scott; A J Hall; R Dagan; J M Dixon; S J Eykyn; A Fenoll; M Hortal; L P Jetté; James Jorgensen; F Lamothe; C Latorre; J T Macfarlane; D M Shlaes; L E Smart; A Taunay
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(6):973-81.
1996: Arthur L Barry; Peter C Fuchs; S D Allen; S D Brown; James Jorgensen; Fred C Tenover
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits.
The Journal of antimicrobial chemotherapy 1996;37(2):365-9.
1995: P C Fuchs; A L Barry; Fred C Tenover; S D Allen; James Jorgensen; P R Murray
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods.
The Journal of antimicrobial chemotherapy 1995;36(5):781-6.
1995: F Moreno; C Crisp; James Jorgensen; Jan Patterson
Methicillin-resistant Staphylococcus aureus as a community organism.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(5):1308-12.
1995: F Moreno; P Grota; C Crisp; K Magnon; G P Melcher; James Jorgensen; Jan Patterson
Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(5):1234-7.
1995: Jana M Swenson; N C Clark; D F Sahm; M J Ferraro; G Doern; J Hindler; James Jorgensen; Michael A Pfaller; L B Reller; M P Weinstein
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci.
Journal of clinical microbiology 1995;33(11):3019-21.
1995: G Valero; Jay Peters; James Jorgensen; John Graybill
Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review.
American journal of respiratory and critical care medicine 1995;152(5 Pt 1):1555-7.
1995: F Moreno; C Crisp; James Jorgensen; Jan Patterson
The clinical and molecular epidemiology of bacteremias at a university hospital caused by pneumococci not susceptible to penicillin.
The Journal of infectious diseases 1995;172(2):427-32.
1995: D L Sewell; Arthur L Barry; S D Allen; Peter C Fuchs; James Jorgensen; Fred C Tenover
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628).
Diagnostic microbiology and infectious disease 1995;21(3):175-9.
1995: Arthur L Barry; Peter C Fuchs; S D Allen; Fred C Tenover; James Jorgensen; L B Reller
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
Journal of clinical microbiology 1995;33(1):235-8.
1994: A L Barry; S D Allen; P C Fuchs; James Jorgensen; Michael A Pfaller
Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin with Pseudomonas aeruginosa ATCC 27853.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(12):1087-9.
1994: Arthur L Barry; P Fuchs; Fred C Tenover; S Allen; D Hardy; James Jorgensen; J McLaughlin; L Reller
Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(10):822-6.
1994: James Jorgensen; J M Swenson; Fred C Tenover; M J Ferraro; J A Hindler; P R Murray
Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.
Journal of clinical microbiology 1994;32(10):2448-59.
1994: F Moreno; James Jorgensen; Marc Weiner
An old antibiotic for a new multiple-resistant Enterococcus faecium?
Diagnostic microbiology and infectious disease 1994;20(1):41-3.
1994: Thomas C Hardin; S C Butler; S Ross; J H Wakeford; James Jorgensen
Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
Pharmacotherapy 1994;14(2):147-52.
1994: A L Barry; S D Allen; P C Fuchs; James Jorgensen; Michael A Pfaller
Quality control parameters for broth microdilution susceptibility testing of amoxicillin and amoxicillin-clavulanic acid.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(2):186-8.
1994: James Jorgensen
Areas of recent emphasis of the National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility Testing.
Advances in experimental medicine and biology 1994;349():61-5.
1994: James Jorgensen; M J Ferraro; M Leticia McElmeel; J Spargo; J M Swenson; Fred C Tenover
Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test.
Journal of clinical microbiology 1994;32(1):159-63.
1993: Fred C Tenover; J Swenson; M J Ferraro; J Hindler; James Jorgensen; P Murray
Cefuroxime screening test for pneumococci.
Journal of clinical microbiology 1993;31(11):3078-9.
1993: James Jorgensen
Selection criteria for an antimicrobial susceptibility testing system.
Journal of clinical microbiology 1993;31(11):2841-4.
1993: Arthur L Barry; Peter C Fuchs; S D Allen; James Jorgensen; Fred C Tenover; P R Murray; D J Hardy; C N Baker
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.
Journal of clinical microbiology 1993;31(9):2375-80.
1993: L L Dever; James Jorgensen; A G Barbour
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.
Antimicrobial agents and chemotherapy 1993;37(8):1704-6.
1993: James Jorgensen
Antimicrobial susceptibility testing of bacteria that grow aerobically.
Infectious disease clinics of North America 1993;7(2):393-409.
1993: L L Dever; James Jorgensen; A G Barbour
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.
Antimicrobial agents and chemotherapy 1993;37(5):1115-21.
1993: James Jorgensen
Selection of antimicrobial agents for routine testing in a clinical microbiology laboratory.
Diagnostic microbiology and infectious disease 1993;16(3):245-9.
1993: Gordon L Archer; P Auger; G V Doern; M J Ferraro; P C Fuchs; James Jorgensen; Donald E Low; P R Murray; L B Reller; C W Stratton
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.
Diagnostic microbiology and infectious disease 1993;16(3):223-6.
1993: Matthew J Dolan; M T Wong; Russell Regnery; James Jorgensen; M Garcia; Jay Peters; D Drehner
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease.
Annals of internal medicine 1993;118(5):331-6.
1993: Arthur L Barry; Peter C Fuchs; James Jorgensen; Fred C Tenover; S D Allen; D J Hardy; J C McLaughlin
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.
Journal of clinical microbiology 1993;31(3):751-3.
1992: Arthur L Barry; James Jorgensen; D J Hardy; S D Allen; C N Baker; Peter C Fuchs; J C McLaughlin
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.
Journal of clinical microbiology 1992;30(11):3013-5.
1992: L L Dever; James Jorgensen; A G Barbour
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
Journal of clinical microbiology 1992;30(10):2692-7.
1992: Arthur L Barry; James Jorgensen; D J Hardy; S D Allen; C N Baker
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams.
Journal of clinical microbiology 1992;30(8):2033-7.
1992: James Jorgensen; A L Barry; G V Doern; M J Ferraro; P R Murray
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Journal of clinical microbiology 1992;30(8):2029-32.
1992: L L Dever; J W Martin; B Seaworth; James Jorgensen
Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(6):1195-200.
1992: James Jorgensen
Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(5):1119-23.
1992: James Jorgensen; G V Doern; M J Ferraro; C C Knapp; J M Swenson; J A Washington
Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.
Journal of clinical microbiology 1992;30(4):961-6.
1991: James Jorgensen; L A Maher; A W Howell
Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli.
Antimicrobial agents and chemotherapy 1991;35(11):2410-4.
1991: G V Doern; E H Gerlach; James Jorgensen; P R Murray; C Thornsberry; J A Washington
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium.
Diagnostic microbiology and infectious disease 1991;14(6):485-93.
1991: James Jorgensen; L A Maher; A W Howell
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1991;35(7):1524-6.
1991: James Jorgensen; L A Maher; A W Howell
Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
Antimicrobial agents and chemotherapy 1991;35(3):600-2.
1991: Arthur L Barry; James Jorgensen; D J Hardy
Reproducibility of disc susceptibility tests with Haemophilus influenzae.
The Journal of antimicrobial chemotherapy 1991;27(3):295-301.
1991: James Jorgensen
Global perspective on antimicrobial resistance in Haemophilus influenzae.
Journal of chemotherapy (Florence, Italy) 1991;3 Suppl 1():155-7.
1991: James Jorgensen; A W Howell; L A Maher
Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test.
Journal of clinical microbiology 1991;29(1):109-14.
1991: James Jorgensen
Mechanisms of methicillin resistance in Staphylococcus aureus and methods for laboratory detection.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1991;12(1):14-9.
1990: James Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
Antimicrobial agents and chemotherapy 1990;34(11):2075-80.
1990: C E Smith; B S Tillman; A W Howell; R N Longfield; James Jorgensen
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
Antimicrobial agents and chemotherapy 1990;34(6):1290-3.
1990: G V Doern; James Jorgensen; C Thornsberry; H Snapper
Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(5):329-36.
1990: James Jorgensen; A W Howell; L A Maher
Antimicrobial susceptibility testing of less commonly isolated Haemophilus species using Haemophilus test medium.
Journal of clinical microbiology 1990;28(5):985-8.
1990: James Jorgensen; L A Maher; A W Howell
Use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae.
Journal of clinical microbiology 1990;28(3):430-4.
1989: J J Farmer; James Jorgensen; Patrick A D Grimont; R J Akhurst; G O Poinar; Elisabeth Ageron; G V Pierce; J A Smith; G P Carter; K L Wilson
Xenorhabdus luminescens (DNA hybridization group 5) from human clinical specimens.
Journal of clinical microbiology 1989;27(7):1594-600.
1989: James Jorgensen; J S Redding; L A Maher
Antibacterial activity of the new glycopeptide antibiotic SKF104662.
Antimicrobial agents and chemotherapy 1989;33(4):560-1.
1988: Arthur L Barry; P B Fernandes; James Jorgensen; C Thornsberry; D J Hardy; Ronald Jones
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.
Journal of clinical microbiology 1988;26(11):2415-20.
1988: James Jorgensen; J S Redding; L A Maher
Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.
Antimicrobial agents and chemotherapy 1988;32(10):1477-80.
1988: James Jorgensen; L A Maher; J S Redding
Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae.
Journal of clinical microbiology 1988;26(9):1887-9.
1988: James Jorgensen; J S Redding; L A Maher; P E Ramirez
Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.
Journal of clinical microbiology 1988;26(9):1675-8.
1988: J G Schwartz; D T Casto; S Ayo; J J Carnahan; James Jorgensen
A commercial enzyme immunoassay method (EMIT) compared with liquid chromatography and bioassay methods for measurement of chloramphenicol.
Clinical chemistry 1988;34(9):1872-5.
1988: G V Doern; James Jorgensen; C Thornsberry; D A Preston; T Tubert; J S Redding; L A Maher
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1988;32(2):180-5.
1988: James Jorgensen; G V Doern; C Thornsberry; D A Preston; J S Redding; L A Maher; T Tubert
Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
Diagnostic microbiology and infectious disease 1988;9(1):27-32.
1987: James Jorgensen; J S Redding; L A Maher; A W Howell
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
Journal of clinical microbiology 1987;25(11):2105-13.
1987: M A Saubolle; James Jorgensen
Use of the Limulus amebocyte lysate test as a cost-effective screen for gram-negative agents of meningitis.
Diagnostic microbiology and infectious disease 1987;7(3):177-83.
1987: James Jorgensen; L A Maher; J S Redding
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
European journal of clinical microbiology 1987;6(1):91-6.
1986: James Jorgensen
Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA.
European journal of clinical microbiology 1986;5(6):693-6.
1986: James Jorgensen; J S Redding; A W Howell
Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1986;29(6):1090-1.
1986: James Jorgensen; J S Redding; A W Howell
In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1986;29(5):921-2.
1986: James Jorgensen; J S Redding; A W Howell
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
Journal of clinical microbiology 1986;23(3):545-50.
1986: D L Calhoun; G D Roberts; John N Galgiani; JOHN BENNETT; D S Feingold; James Jorgensen; G S Kobayashi; S Shadomy
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.
Journal of clinical microbiology 1986;23(2):298-301.
1986: G V Doern; James Jorgensen; C Thornsberry; D A Preston
Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
Diagnostic microbiology and infectious disease 1986;4(2):95-107.
1985: James Jorgensen
Rapid methods in clinical microbiology. Clinical situations in which rapid methods may best be applied.
Diagnostic microbiology and infectious disease 1985;3(6 Suppl):3S-7S.
1985: C A Bodet; James Jorgensen; D J Drutz
Antibacterial activities of antineoplastic agents.
Antimicrobial agents and chemotherapy 1985;28(3):437-9.
1985: C A Bodet; James Jorgensen; D J Drutz
Simplified bioassay method for measurement of flucytosine or ketoconazole.
Journal of clinical microbiology 1985;22(2):157-60.
1985: James Jorgensen
Susceptibility test methods which may be able to predict the emergence of resistance to newer beta- lactam antibiotics.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1985;4(1):7-13.
1985: James Jorgensen
Rapid diagnosis of genitourinary infections by use of the Limulus lysate amebocyte test.
Progress in clinical and biological research 1985;189():387-403.
1984: R J Almeida; James Jorgensen
Comparison of adherence and urine growth rate properties of Staphylococcus saprophyticus and Staphylococcus epidermidis.
European journal of clinical microbiology 1984;3(6):542-5.
1984: James Jorgensen; J W Dyke; N G Helgeson; B H Cooper; J S Redding; S A Crawford; M T Andruszewski; S A Prowant
Collaborative evaluation of the Abbott Avantage system for identification of frequently isolated nonfermentative or oxidase-positive gram-negative bacilli.
Journal of clinical microbiology 1984;20(5):899-904.
1984: S C Ebert; James Jorgensen; D J Drutz; W A Clementi
Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods.
Journal of clinical microbiology 1984;20(4):701-5.
1984: James Jorgensen; J Redding; J E Johnson; V Holloway; R J Almeida
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems.
Journal of clinical microbiology 1984;20(3):430-3.
1984: D A Strandberg; James Jorgensen; D J Drutz
Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.
Diagnostic microbiology and infectious disease 1984;2(4):333-7.
1984: S A Klotz; James Jorgensen; F J Buckwold; P C Craven
Typhoid fever. An epidemic with remarkably few clinical signs and symptoms.
Archives of internal medicine 1984;144(3):533-7.
1984: M A Buesing; James Jorgensen
In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.
Antimicrobial agents and chemotherapy 1984;25(2):283-5.
1983: J E Johnson; James Jorgensen; S A Crawford; J S Redding; R C Pruneda
Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli.
Journal of clinical microbiology 1983;18(6):1301-9.
1983: C M Kerr; J R Perfect; P C Craven; James Jorgensen; D J Drutz; J D Shelburne; H A Gallis; R A Gutman
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.
Annals of internal medicine 1983;99(3):334-6.
1983: D A Strandberg; James Jorgensen; D J Drutz
Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
Antimicrobial agents and chemotherapy 1983;24(2):282-6.
1983: R J Almeida; James Jorgensen; J E Johnson
Evaluation of the automicrobic system gram-positive identification card for species identification of coagulase-negative staphylococci.
Journal of clinical microbiology 1983;18(2):438-9.
1983: R J Almeida; James Jorgensen
Identification of coagulase-negative staphylococci with the API STAPH-IDENT system.
Journal of clinical microbiology 1983;18(2):254-7.
1983: P Duff; James Jorgensen; R S Gibbs; J D Blanco; G Alexander; Y S Castaneda
Serum gentamicin levels in patients with post-cesarean endomyometritis.
Obstetrics and gynecology 1983;61(6):723-7.
1983: James Jorgensen; S A Crawford; G A Alexander
Rapid identification of group D streptococci with the API 20S system.
Journal of clinical microbiology 1983;17(6):1096-8.
1983: James Jorgensen; J E Johnson; G A Alexander; R Paxson; G L Alderson
Comparison of automated and rapid manual methods for the same-day identification of Enterobacteriaceae.
American journal of clinical pathology 1983;79(6):683-7.
1983: R J Almeida; James Jorgensen
Rapid determination of novobiocin resistance of coagulase-negative staphylococci with the MS-2 system.
Journal of clinical microbiology 1983;17(3):558-60.
1983: J D Blanco; James Jorgensen; Y S Castaneda; S A Crawford
Ceftazidime levels in human breast milk.
Antimicrobial agents and chemotherapy 1983;23(3):479-80.
1983: P C Craven; John Graybill; James Jorgensen; William E Dismukes; B E Levine
High-dose ketoconazole for treatment of fungal infections of the central nervous system.
Annals of internal medicine 1983;98(2):160-7.
1983: John Graybill; John N Galgiani; James Jorgensen; D A Strandberg
Ketoconazole therapy for fungal urinary tract infections.
The Journal of urology 1983;129(1):68-70.
1982: R J Almeida; James Jorgensen
Use of Mueller-Hinton agar to determine novobiocin susceptibility of coagulase-negative staphylococci.
Journal of clinical microbiology 1982;16(6):1155-6.
1982: P Duff; R S Gibbs; James Jorgensen; G Alexander
The pharmacokinetics of prophylactic antibiotics administered by intraoperative irrigation at the time of cesarean section.
Obstetrics and gynecology 1982;60(4):409-12.
1982: James Jorgensen; G A Alexander
Rapid detection of significant bacteriuria by use of an automated Limulus amoebocyte lysate assay.
Journal of clinical microbiology 1982;16(3):587-9.
1982: J E Johnson; S Crawford; James Jorgensen
Evaluation of the macro-vue latex agglutination test for quantitation of gentamicin in human serum.
Journal of clinical microbiology 1982;16(2):299-302.
1982: James Jorgensen; S A Crawford; G A Alexander
Pyridinium-2-azo-p-dimethylaniline chromophore, a new chromogenic cephalosporin for rapid beta-lactamase testing.
Antimicrobial agents and chemotherapy 1982;22(1):162-4.
1982: P C Craven; John Graybill; James Jorgensen
Ketoconazole therapy of murine cryptococcal meningitis.
The American review of respiratory disease 1982;125(6):696-700.
1982: James Jorgensen; A S Reichler
Automation of Limulus amoebocyte lysate pyrogen testing.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association 1982;36(3):96-8.
1981: James Jorgensen; G A Alexander
Rapid bioassay for chloramphenicol in the presence of other antibiotics.
American journal of clinical pathology 1981;76(4):472-5.
1981: P R Murray; James Jorgensen
Quantitative susceptibility test methods in major United States medical centers.
Antimicrobial agents and chemotherapy 1981;20(1):66-70.
1981: James Jorgensen; G A Alexander; John Graybill; D J Drutz
Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid.
Antimicrobial agents and chemotherapy 1981;20(1):59-62.
1981: James Jorgensen; G A Alexander
Automation of the Limulus amoebocyte lysate test by using the Abbott MS-2 microbiology system.
Applied and environmental microbiology 1981;41(6):1316-20.
1981: K K Tu; James Jorgensen; C W Stratton
A rapid paper-disc test for penicillinase.
American journal of clinical pathology 1981;75(4):557-9.
1980: James Jorgensen; S A Crawford; G A Alexander
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Antimicrobial agents and chemotherapy 1980;17(6):937-42.
1980: James Jorgensen; S A Crawford; G A Alexander
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Antimicrobial agents and chemotherapy 1980;17(5):901-4.
1980: James Jorgensen; G A Alexander; J E Johnson
Practical anaerobic broth-disk elution susceptibility test.
Antimicrobial agents and chemotherapy 1980;17(4):740-2.
1980: James Jorgensen; S A Crawford; G A Alexander
In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1980;17(3):516-7.
1979: James Jorgensen; J C Lee; G A Alexander; H W Wolf
Comparison of Limulus assay, standard plate count, and total coliform count for microbiological assessment of renovated wastewater.
Applied and environmental microbiology 1979;37(5):928-31.
1979: R W Wolters; James Jorgensen; E Calzada; R H Poirier
Limulus lysate assay for early detection of certain Gram-negative corneal infections.
Archives of ophthalmology 1979;97(5):875-7.
1979: James Jorgensen
Detection of endotoxin in urine: rapid diagnosis of gram negative bacteriuria by the Limulus assay.
Progress in clinical and biological research 1979;29():255-64.
1978: James Jorgensen; P Holmes; W L Williams; J L Harris
Computerization of a hospital clinical microbiology laboratory.
American journal of clinical pathology 1978;69(6):605-14.
1978: James Jorgensen; G A Alexander
Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1978;13(2):342-3.
1978: James Jorgensen; J C Lee
Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay.
Journal of clinical microbiology 1978;7(1):12-7.
1977: James Jorgensen; J C Lee
Rapid bioassay for clindamycin alone and in the presence of aminoglycoside antibiotics.
The Journal of infectious diseases 1977;136(3):422-7.
1977: R H Poirier; James Jorgensen
Endotoxin assay for rapid diagnosis of pseudomonas corneal ulcer.
Lancet 1977;2(8028):85-6.
1977: James Jorgensen; J C Lee; G A Alexander
Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae.
Antimicrobial agents and chemotherapy 1977;11(6):1087-8.
1977: T H Miller; L L Priano; James Jorgensen; D L Traber
Cardiorespiratory effects of Pseudomonas and E. coli endotoxins in the awake dog.
The American journal of physiology 1977;232(6):H682-9.
1977: P C Craven; James Jorgensen; R L Kaspar; D J Drutz
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
The American journal of medicine 1977;62(6):902-10.
1977: James Jorgensen; J C Lee; P M Jones
Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 1977;11(3):415-9.
1977: James Jorgensen; J C Lee
Standardized disk-diffusion susceptibility test for Haemophilus influenzae.
American journal of clinical pathology 1977;67(3):264-8.
1976: James Jorgensen; J C Lee; H R Pahren
Rapid detection of bacterial endotoxins in drinking water and renovated wastewater.
Applied and environmental microbiology 1976;32(3):347-51.
1975: James Jorgensen; J C Lee
Microdilution technique for antimicrobial susceptibility testing of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1975;8(5):610-1.
1975: E E Moody; M D Trousdale; James Jorgensen; A Shelokov
Bacteriophages and endotoxin in licensed live-virus vaccines.
The Journal of infectious diseases 1975;131(5):588-91.
1975: R F Smith; H A Linares; James Jorgensen
Bacteremia and postmortem microbiology in burned children.
American journal of clinical pathology 1975;63(4):502-8.
1975: James Jorgensen; P M Jones
Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1975;7(2):186-90.
1975: James Jorgensen; P M Jones
Comparative evaluation of the Limulus assay and the direct Gram stain for detection of significant bacteriuria.
American journal of clinical pathology 1975;63(1):142-8.
1974: James Jorgensen; R F Smith
Measurement of bound and free endotoxin by the Limulus assay.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1974;146(4):1024-31.
1973: James Jorgensen; R F Smith
Rapid detection of contaminated intravenous fluids using the Limulus in vitro endotoxin assay.
Applied microbiology 1973;26(4):521-4.
1973: N C Trippodo; James Jorgensen; L L Priano; D L Traber
Cerebrospinal fluid levels of endotoxin during endotoxemia.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;143(4):932-7.
1973: James Jorgensen; H F Carvajal; B E Chipps; R F Smith
Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay.
Applied microbiology 1973;26(1):38-42.
1973: James Jorgensen; R F Smith
Preparation, sensitivity, and specificity of Limulus lysate for endotoxin assay.
Applied microbiology 1973;26(1):43-8.
1973: R F Smith; C L Bettge; S L Dayton; James Jorgensen
Characterization of Staphylococcus aureus in a pediatric burn unit.
Applied microbiology 1973;25(1):15-20.
1972: R F Smith; James Jorgensen; C L Bettge; S L Dayton
Evaluation of selective and differential media in the isolation and enumeration of airborne Staphylococcus aureus.
Health laboratory science 1972;9(4):284-8.